"Friends or foes": a new perspective of tumour metabolic transcriptional modification

Tong Shi1,2, Qishun Geng1,2, Zhaoran Wang1,2

  • 1China-Japan Friendship Clinical Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Cell Death & Disease
|February 17, 2025
PubMed

Insights

This study reveals how tumor metabolism influences cancer progression via transcriptional regulation, offering new strategies for personalized cancer treatment and drug combinations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolomics

Background:

  • Energy metabolism is crucial in cancer treatment and diagnosis.
  • Current research on tumor metabolism primarily examines metabolic products, overlooking transcriptional regulation mechanisms.

Purpose of the Study:

  • To propose a novel perspective on tumor progression by exploring the interplay between metabolism and transcription.
  • To elucidate how tumor metabolism impacts progression through transcriptional modifications.
  • To provide a new framework for optimizing cancer treatment strategies.

Main Methods:

  • Development of a comprehensive network to map interactions between metabolism and transcription.
  • Analysis of transcriptional modifications driven by tumor metabolic alterations.

Main Results:

  • Identification of key interactions between metabolic pathways and transcriptional regulation in tumors.
  • Demonstration of how metabolic changes lead to specific transcriptional modifications affecting tumor progression.

Conclusions:

  • Understanding the metabolism-transcription network offers a novel approach to cancer treatment.
  • This perspective can help overcome current therapeutic challenges and advance personalized medicine and combination therapies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K